Cis vs Trans MK-7: What Ingredient Buyers Should Check

Conceptual isomer-quality image; numerical criteria must be verified against the applicable current TDS and batch COA. “All-trans” is useful positioning, but qualification still requires a numerical specification, analytical method and representative batch result. Key takeaways Assay and isomer profile describe different quality attributes. The supplied Ureda T-1500 and T-4500 TDS documents set cis-MK-7 at no […]

How to Choose an MK-7 Oil Concentration

Conceptual concentration-selection image; confirm the applicable current specification for the exact commercial grade. Compare verified 1,500 and 4,500 ppm grades first; treat 1% and 5% oils as project options requiring an applicable current specification. Key takeaways Start with a mass-balance calculation and minimum reliable weighing quantity. Higher potency reduces carrier load but magnifies weighing and […]

MK-7 Oil vs Powder: Which Format Fits Your Product?

Conceptual ingredient-format image for formulation discussion; not a representation of final commercial packaging. Choose by dosage form, target dose, process, companion ingredients and shelf-life plan—not by catalogue potency alone. Key takeaways Oil is the natural starting point for softgels, drops and lipid systems. MCC premix makes microgram-level addition more manageable in dry products. Protected powder […]

Request For A Quote

Please fill out the form below, and we will contact you within 24 hours.

If you have any questions, feel free to contact us at sales@uredapharm.com